Back to Search
FADLO KHURI, M.D.
M.D.
Medical Oncology Physician
NPI: 1366559023Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
52284(GA)
Research & Publications (20)
Weighing the hazards of erythropoiesis stimulation in patients with cancer.
PMID 17568023·N Engl J Med·2007
8-other
Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
PMID 16595780·J Natl Cancer Inst·2006
3-trial
Novel agents and incremental advances in the treatment of head and neck cancer.
PMID 15124127·Semin Oncol·2004
6-review
Molecularly targeted approaches to the chemoprevention of lung cancer.
PMID 15217968·Clin Cancer Res·2004
6-review
Phase I study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in solid tumors.
PMID 15131032·Clin Cancer Res·2004
3-trial
Primary and secondary prevention of non-small-cell lung cancer: the SPORE Trials of Lung Cancer Prevention.
PMID 14641993·Clin Lung Cancer·2003
6-review
Quantum dot-based quantification revealed differences in subcellular localization of EGFR and E-cadherin between EGFR-TKI sensitive and insensitive cancer cells.
PMID 19433879·Nanotechnology·2009
8-other
A phase II study of Lonafarnib (SCH66336) in patients with chemorefractory, advanced squamous cell carcinoma of the head and neck.
PMID 19433965·Am J Clin Oncol·2009
3-trial
Synergistic growth inhibition of squamous cell carcinoma of the head and neck by erlotinib and epigallocatechin-3-gallate: the role of p53-dependent inhibition of nuclear factor-kappaB.
PMID 19470788·Cancer Prev Res (Phila)·2009
8-other
Phase I trial of weekly topotecan and gemcitabine in patients with solid tumors.
PMID 19194117·Am J Clin Oncol·2009
3-trial
Phosphorylated eukaryotic translation initiation factor 4 (eIF4E) is elevated in human cancer tissues.
PMID 19483468·Cancer Biol Ther·2009
8-other
Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer.
PMID 19289628·J Clin Oncol·2009
8-other
The role of the taxanes in the treatment of older patients with advanced stage non-small cell lung cancer.
PMID 19342473·Oncologist·2009
6-review
Optimizing systemic therapy in squamous cell carcinoma of the head and neck with a focus on targeted agents.
PMID 19370807·Curr Opin Oncol·2009
6-review
The glycolytic inhibitor 2-deoxyglucose activates multiple prosurvival pathways through IGF1R.
PMID 19574224·J Biol Chem·2009
8-other
The protein farnesyltransferase regulates HDAC6 activity in a microtubule-dependent manner.
PMID 19228685·J Biol Chem·2009
8-other
Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants.
PMID 19584075·Cancer Prev Res (Phila)·2009
8-other
Distinct growth factor-induced dynamic mass redistribution (DMR) profiles for monitoring oncogenic signaling pathways in various cancer cells.
PMID 19604037·J Recept Signal Transduct Res·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1365 CLIFTON RD NE
ATLANTA, GA 30322 - Phone
- (404) 778-1900
Quick Facts
- NPI
- 1366559023
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile